In July, RaySearch Laboratories AB received regulatory market approval by the Chinese regulatory agency CFDA for RaySearch’s treatment planning system RayStation and has now gotten the first order.
The order was received from Ganzhou People’s Hospital in Ganzhou, Jiangxi Province, China where it will be used for treatment planning of both conventional treatments and IMRT.
“China is one of the largest radiation therapy markets in the world today and it has perhaps the largest growth potential of all markets. This means that we are of course happy to receive our first order so quickly after securing regulatory approval. Kang Li Da is in the final stages of negotiations with several other clinics as well so we have high hopes for this market for the remainder of the year”, says Johan Löf, CEO of RaySearch in a press release.
The order is the second one in a week for RaySearch as the medtech company earlier landed a an order of the RayStation system to the US Provision Center for Proton Therapy.